8
Tetrahedron
1H NMR (500 MHz, CD3OD): δ = 3.86-3.77 (m, 2H), 3.62-3.54
ESI-HRMS calcd for C26H38O6Na ([M+Na]+): 435.2506; found:
ACCEPTED MANUSCRIPT
(m, 1H), 3.52-3.39 (m, 2H), 1.71-1.20 (m, 16H), 0.92 (t, J = 6.7
Hz, 3H) ppm; 13C NMR (125 MHz, CD3OD): δ = 73.23, 73.21,
69.3, 69.20, 69.17, 67.38, 67.36, 45.57, 45.54, 39.20, 39.18,
34.42, 34.38, 33.1, 26.5, 23.7, 22.8, 14.4 ppm; FT-IR (film of a
conc. solution in CH2Cl2): 3315, 2931, 2857, 1459, 1409, 1376,
1351, 1176, 1064, 1030, 901, 831, 737 cm–1. EI-MS m/z (%) 199
(6.7, (M+ – CH2OH and H2O), 185 (2.1), 181 (3.3), 115 (58.2),
109 (34.6), 97 (38.5), 55 (100). EI-HRMS calcd for C12H23O2
(M+ – CH2OH and H2O): 199.1698; found: 199.1702.
435.2519.
4.18. Synthesis of 34 via cross metathesis between 32 and 14
followed by hydrogenation.
The same procedure described above for coupling of 10 with
14 followed by hydrogenation to afford 17 was employed (with
32 to replace 10). Data for 34 (a colorless oil, 250 mg, 0.54
mmol, 50% for two steps from 32): [α]D24 +6.9 (c 1.0, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.7 Hz, 4H), 6.85 (d, J
= 8.1 Hz, 4H), 4.47-4.34 (m, 4H), 3.79 (s, 6H), 3.59 (t, J = 6.1
Hz, 2H), 3.49-3.39 (m, 2H), 2.01-1.88 (m, 1H), 1.76-1.19 (m,
16H), 0.88 (t, J = 6.6 Hz, 3H) ppm; 13C NMR (100 MHz,
CDCl3): δ = 159.06, 159.03, 131.0, 130.9, 129.4, 113.7, 75.6,
75.5, 70.2, 70.1, 62.8, 55.23, 55.22, 38.6, 34.0, 33.8, 32.8, 32.0,
24.8, 22.6, 21.4, 14.0 ppm; FT-IR (film): 3460, 2932, 2859,
1734, 1612, 1586, 1513, 1464, 1364, 1302, 1248, 1173, 1061,
1036, 820 cm–1. ESI-MS m/z 481.5 ([M+Na]+). ESI-HRMS calcd
for C28H42O5Na ([M+Na]+): 481.2925; found: 481.2934.
4.15. PMB protection of diol 29 to afford 30.
The same procedure given above for conversion of 7 into 8
was employed (with 29 to place of 7). Data for 30 (a colorless
27
1
oil, 1.490 g, 63% from 29): [α]D +3.4 (c 1.0, CHCl3); H NMR
(500 MHz, CDCl3): δ = 7.24 (d, J = 9.1 Hz, 2H), 7.21 (d, J = 9.2
Hz, 2H), 6.89 (d, J = 9.0 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 4.59
(d, J = 11.1 Hz, 1H), 4.49 (d, J = 11.2 Hz, 1H), 4.41 (s, 2H), 4.12
(dt, J = 4.6, 6.9 Hz, 1H), 4.01 (dd, J = 8.4, 6.7Hz, 1H), 3.86 (t, J
= 7.4 Hz, 1H), 3.79 (s, 6H), 3.60-3.65 (m, 1H), 3.51 (quint, J =
6.0 Hz, 1H), 1.85 (dt, J = 14.7, 6.8 Hz, 1H), 1.65-1.59 (m, 1H ),
1.50-1.44 (m, 2H ), 1.43 (s, 3H ), 1.35 (s, 3H), 1.31-1.17 (m, 6H),
0.88 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ =
159.2, 131.0, 130.6, 129.5, 129.3, 113.69, 113.67, 109.0, 78.6,
75.6, 75.5, 72.2, 70.2, 66.0, 55.24, 55.21, 36.3, 33.9, 32.0, 26.5,
25.3, 24.8, 22.6, 14.0 ppm; FT-IR (film): 2933, 2860, 1612,
1514, 1464, 1370, 1301, 1248, 1173, 1069, 1036, 821 cm–1. ESI-
MS m/z 509.7 ([M+Na]+). ESI-HRMS calcd for C29H42O6Na
([M+Na]+): 509.2874; found: 509.2884.
4.19. Oxidation of alcohol 34 to afford aldehyde 35.
The same procedure described above for oxidation of 17 to
give 18 was employed (with 34 to replace 17). Data for 35 (a
colorless oil, 85 mg, 0.19 mmol, 93% from 34): [α]D +13.7 (c
27
1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 9.70 (t, J = 1.9 Hz,
1H), 7.22 (d, J = 7.6 Hz, 4H), 6.85 (d, J = 8.6 Hz, 4H), 4.48-4.33
(m, 4H), 3.80 (s, 6H), 3.51-3.38 (m, 2H), 2.34 (t, J = 7.4 Hz, 2H),
1.99-1.89 (m, 1H), 1.80-1.17 (m, 13H), 0.89 (t, J = 6.8 Hz, 3H)
ppm; 13C NMR (100 MHz, CDCl3): δ = 202.6, 159.18, 159.15,
131.0, 130.9, 129.5, 113.78, 113.76, 75.5, 75.2, 70.28, 70.22,
55.3, 43.8, 38.5, 34.0, 33.4, 32.0, 24.9, 22.7, 17.9, 14.1 ppm; FT-
IR (film): 2932, 2859, 1725, 1612, 1513, 1464, 1301, 1248,
1173, 1064, 1036, 821 cm–1. ESI-MS m/z 479.6 ([M+Na]+). ESI-
HRMS calcd for C28H40O5Na ([M+Na]+): 479.2768; found:
479.2779.
4.16. Hydrolysis of the acetonide in 30 to afford diol 31.
The same procedure described above for the conversion of 8
to 9 was employed (with 30 to replace 8). Data for 31 (a colorless
oil, 709 mg, 1.59 mmol, 83% from 30): [α]D +59.2 (c 1.0,
23
1
CHCl3). H NMR (500 MHz, CDCl3): δ = 7.23 (d, J = 8.1 Hz,
2H), 7.22 (d, J = 9.0 Hz, 2H), 6.84 (d, J = 8.3 Hz, 4H), 4.50 (d, J
= 10.9 Hz, 1H), 4.48 (d, J = 10.7 Hz, 1H), 4.38 (d, J = 12.4 Hz,
1H), 4.36 (d, J = 10.4 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 3.74
(dd, J =10.1, 2.4Hz, 1H), 3.71-3.56 (m, 4H), 1.93-1.86 (m, 1H),
1.85-1.79 (m, 1H), 1.64-1.49 (m, 2H), 1.37-1.24 (m, 6H), 0.90 (t,
J = 6.8 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 159.3,
130.2, 130.0, 129.6, 129.5, 113.85, 113.83, 77.3, 75.2, 72.3, 71.3,
70.5, 63.9, 55.2, 34.0, 33.3, 31.9, 24.5, 22.6, 14.0 ppm; FT-IR
(film): 3478, 2931, 2858, 1849, 1612, 1514, 1464, 1301, 1248,
1173, 1073, 1035, 821 cm–1. ESI-MS m/z 469.5 ([M+Na]+). ESI-
HRMS calcd for C26H38O6Na ([M+Na]+): 469.2561; found:
469.2568.
4.20. Conversion of 35 into 36.
A solution of LiAlH4 (1.0 M, in THF, 0.27 mL, 0.27 mmol)
was added dropwise to a solution of CrCl3 (166 mg, 1.05 mmol)
in dry THF (0.5 mL) stirred in an ice-water bath under argon
(balloon). The initially purple solution turned light green, with a
lot of gas bubbles evolved. After completion of the addition, the
cooling bath was removed. The mixture was heated to reflux
(still under argon), while a solution of aldehyde 35 (48 mg, 0.105
mmol) and CHCl3 (21ꢀL, 0.21 mmol) in dry THF (1.5 mL) was
introduced. The solution turned dark-red. The mixture was then
heated with stirring for 3 h. The heating bath was removed. The
reaction was quenched by addition of water. The reaction mixture
was diluted with EtOAc (10 mL), washed water (3 mL), aq. sat.
NaHCO3 and brine before being dried over anhydrous Na2SO4.
Removal of the solvent by rotary evaporation and column
chromatography (10:1 PE/EtOAc) on silica gel gave 36 as a
colorless oil (a 92:8 inseparable (E)/(Z) mixture, 37 mg, 0.077
mmol, 73% from 35). [α]D26 +13.5 (c 1.0, CHCl3). 1H NMR (500
MHz, CDCl3): δ = 7.22(d, J = 8.3 Hz, 4H), 6.85 (d, J = 7.7 Hz,
4H), 6.01(d, J = 6.4 Hz, 0.08H), 5.90 (d, J = 13.0 Hz, 0.92H),
5.85 (dt, J = 13.2, 7.4 Hz, 0.92H), 5.71 (q, J = 14.3, 7.3 Hz,
0.08H), 4.48-4.33 (m, 4H), 3.80 (s, 6H), 3.49-3.38 (m, 2H), 2.07-
1.87 (m, 2H), 1.57-1.40 (m, 6H ), 1.40-1.18 (m, 8H), 0.89 (t, J =
6.8 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 159.13,
159.10, 133.8, 131.0, 130.9, 129.5, 129.4, 116.9, 113.74, 113.72,
75.5, 75.3, 70.3, 70.2, 55.3, 38.6, 34.0, 33.4, 32.0, 30.9, 24.9,
24.6, 22.7, 14.1 ppm; FT-IR (film): 2932, 2858, 1612, 1586,
1513, 1464, 1441, 1301, 1247, 1172, 1067, 1037, 935, 820cm–1.
4.17. Conversion of diol 31 into alkene 32.
The same procedure described above for conversion of 9 to 10
was employed (with 31 to replace 9). Data for 32 (a colorless oil,
576 mg, 1.40 mmol, 100% from 31): [α]D21 –23.7 (c 1.0, CHCl3).
1H NMR (500 MHz, CDCl3): δ = 7.23 (d, J = 8.6 Hz, 2H), 7.20
(d, J = 8.8 Hz, 2 H), 6.86 (d, J = 9.2 Hz, 2H), 6.84 (d, J = 9.1 Hz,
2H), 5.71 (ddd, J = 18.2, 10.2, 8.0 Hz, 1H ), 5.22 (dd, J = 10.3,
2.0 Hz, 1H), 5.15 (dd, J = 17.1, 1.0 Hz, 1H), 4.50 (d, J = 11.0 Hz,
1H), 4.41 (d, J = 10.9 Hz, 1H), 4.34 (d, J = 10.9 Hz, 1H), 4.26 (d,
J = 11.7 Hz, 1H), 3.88 (q, J = 14.5, 7.3 Hz, 1H), 3.79 (s, 6H),
3.45 (dq, J = 6.8, 5.5 Hz, 1H), 2.01 (quint, J = 6.7 Hz, 1H), 1.62-
1.54 (m, 1H), 1.54-1.41 (m, 2H), 1.38-1.17 (m, 6H), 0.87 (t, J =
7.2 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 159.0, 138.9,
131.1, 130.7, 129.4, 129.3, 117.5, 113.68, 113.65, 77.5, 75.4,
70.1, 69.6, 55.22, 55.19, 40.13, 33.8, 31.9, 24.7, 22.6, 14.0 ppm;
FT-IR (film): 2931, 2858, 1736, 1612, 1513, 1465, 1301, 1247,
1172, 1074, 1036, 926, 820 cm–1. ESI-MS m/z 435.4 ([M+Na]+).